JAMIE SMITH: Open Payments
NPI 1003338195 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 18 payments from 9 companies in 2025. Trend: 2023 $1,293 · 2024 $664 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $86 |
| Axsome Therapeutics, Inc. | 4 | $68 |
| Novo Nordisk Inc | 2 | $40 |
| ABBVIE INC. | 2 | $37 |
| Lilly USA, LLC | 2 | $31 |
| Lundbeck LLC | 1 | $24 |
| Ardelyx, Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $16 |
Products named: INGREZZA, Sunosi, MOUNJARO, ABILIFY MAINTENA, Ozempic, IBSRELA, JARDIANCE, UBRELVY.
Industry payments across GA — which companies pay providers there.
